Hancock Whitney Corp Takes Position in Integer Holdings Co. (NYSE:ITGR)

Hancock Whitney Corp acquired a new stake in Integer Holdings Co. (NYSE:ITGR) in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,742 shares of the medical equipment provider’s stock, valued at approximately $203,000.

Several other large investors have also bought and sold shares of the company. Raymond James & Associates boosted its position in shares of Integer by 20.3% during the 4th quarter. Raymond James & Associates now owns 48,946 shares of the medical equipment provider’s stock valued at $4,850,000 after purchasing an additional 8,246 shares in the last quarter. Assenagon Asset Management S.A. acquired a new position in shares of Integer in the 4th quarter valued at $1,375,000. Blue Trust Inc. lifted its stake in Integer by 483.3% during the fourth quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock valued at $45,000 after buying an additional 377 shares in the last quarter. Trust Point Inc. acquired a new stake in shares of Integer during the fourth quarter valued at approximately $874,000. Finally, Mirae Asset Global Investments Co. Ltd. lifted its position in shares of Integer by 6.2% in the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 17,505 shares of the medical equipment provider’s stock valued at $1,734,000 after acquiring an additional 1,016 shares in the last quarter. Institutional investors own 99.29% of the company’s stock.

Integer Stock Performance

Integer stock traded down $3.16 on Friday, hitting $113.00. The company’s stock had a trading volume of 76,246 shares, compared to its average volume of 331,227. The company has a fifty day moving average price of $118.85 and a 200-day moving average price of $113.68. The firm has a market cap of $3.79 billion, a P/E ratio of 40.17, a price-to-earnings-growth ratio of 1.74 and a beta of 1.11. Integer Holdings Co. has a one year low of $69.40 and a one year high of $130.15. The company has a quick ratio of 1.96, a current ratio of 3.29 and a debt-to-equity ratio of 0.73.

Integer (NYSE:ITGR) last posted its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm had revenue of $436.20 million during the quarter, compared to analyst estimates of $437.00 million. During the same quarter in the prior year, the business posted $1.14 earnings per share. The company’s quarterly revenue was up 9.0% compared to the same quarter last year. On average, equities analysts anticipate that Integer Holdings Co. will post 5.31 earnings per share for the current year.

Insider Buying and Selling at Integer

In related news, SVP Andrew Senn sold 5,000 shares of the stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total transaction of $565,700.00. Following the completion of the sale, the senior vice president now owns 4,658 shares in the company, valued at approximately $527,006.12. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider John A. Harris 3,400 shares of the stock in a transaction dated Tuesday, July 30th. The was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP Andrew Senn sold 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 7th. The shares were sold at an average price of $113.14, for a total transaction of $565,700.00. Following the completion of the sale, the senior vice president now directly owns 4,658 shares of the company’s stock, valued at approximately $527,006.12. The disclosure for this sale can be found here. Insiders have sold 28,396 shares of company stock worth $3,391,070 over the last three months. Company insiders own 2.00% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the company. Citigroup lifted their price target on Integer from $118.00 to $124.00 and gave the company a “neutral” rating in a report on Wednesday, May 22nd. KeyCorp raised their price objective on shares of Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a research report on Tuesday, April 9th. Oppenheimer initiated coverage on shares of Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price target on the stock. Bank of America upgraded shares of Integer from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $105.00 to $135.00 in a report on Monday, April 15th. Finally, Benchmark reiterated a “buy” rating and set a $130.00 price target on shares of Integer in a report on Friday, May 10th. Two analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $133.86.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.